OSE Immunotherapeutics (OSE) EUR0.2

Sell:€7.55Buy:€7.63€0.03 (0.40%)

Prices delayed by at least 15 minutes
Sell:€7.55
Buy:€7.63
Change:€0.03 (0.40%)
Prices delayed by at least 15 minutes
Sell:€7.55
Buy:€7.63
Change:€0.03 (0.40%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 November 2024
Maryvonne HianceOther Chairman
Sell
Regular sell transaction (market)
16,702€10.02€167,298.92377,382
8 November 2024
Maryvonne HianceOther Chairman
Sell
Regular sell transaction (market)
13,298€10.00€132,980.00364,084
8 November 2024
Anne-Laure Autret-CornetCFO
Sell
Regular sell transaction (market)
10,000€9.99€99,878.0070,377
13 June 2024
Didier HochDirector
Sell
Regular sell transaction (market)
6,369€7.20€45,879.0953,703
3 June 2024
Maryvonne HianceOther Chairman
Sell
Regular sell transaction (market)
40,000€7.86€314,512.00384,084

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
3 June 2024
Maryvonne HianceOther Chairman
Sell
Regular sell transaction (market)
40,000€7.86€314,512.00384,084
8 November 2024
Maryvonne HianceOther Chairman
Sell
Regular sell transaction (market)
16,702€10.02€167,298.92377,382
8 November 2024
Maryvonne HianceOther Chairman
Sell
Regular sell transaction (market)
13,298€10.00€132,980.00364,084
8 November 2024
Anne-Laure Autret-CornetCFO
Sell
Regular sell transaction (market)
10,000€9.99€99,878.0070,377
13 June 2024
Didier HochDirector
Sell
Regular sell transaction (market)
6,369€7.20€45,879.0953,703

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.